1.
Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66 155 cases and 91 307 controls
by Ye, Zheng
The Lancet (British edition), 2006, Vol.367 (9511), p.651-658
2.
Plasma Biomarkers of Inflammation, Endothelial Function and Hemostasis in Cerebral Small Vessel Disease
by Wiseman, Stewart J
Cerebrovascular diseases (Basel, Switzerland), 2015-09, Vol.40 (3-4), p.157-164
3.
Associations of Inflammatory and Haemostatic Biomarkers with Poor Outcome in Acute Ischaemic Stroke
by Welsh, Paul
Cerebrovascular diseases (Basel, Switzerland), 2009-03, Vol.27 (3), p.247-253
4.
C-reactive protein and its role in metabolic syndrome: mendelian randomisation study
by Timpson, Nicholas J
The Lancet (British edition), 2005-12-03, Vol.366 (9501), p.1954-1959
5.
Adult socioeconomic position, C-reactive protein and interleukin-6 in the Whitehall II prospective study
by GIMENO, David
European journal of epidemiology, 2007-10-01, Vol.22 (10), p.675-683
6.
An Analysis of Prospective Risk Factors for Aortic Stiffness in Men: 20-Year Follow-Up From the Caerphilly Prospective Study
by McEniery, Carmel M
Hypertension (Dallas, Tex. 1979), 2010-07, Vol.56 (1), p.36-43
7.
Common Variants of Large Effect in F12, KNG1, and HRG Are Associated with Activated Partial Thromboplastin Time
by Houlihan, Lorna M
American journal of human genetics, 2010, Vol.86 (4), p.626-631
8.
Thromboprophylaxis for patients at high risk of VTE
by Lowe, Gordon
The Lancet (British edition), 2008, Vol.372 (9643), p.1037-1038
9.
Associations of Circulating C-Reactive Protein and Interleukin-6 with Cancer Risk: Findings from Two Prospective Cohorts and a Meta-Analysis
by Heikkilä, Katriina
Cancer causes & control, 2009-02-01, Vol.20 (1), p.15-26
10.
Genetic Associations for Activated Partial Thromboplastin Time and Prothrombin Time, their Gene Expression Profiles, and Risk of Coronary Artery Disease
by Tang, Weihong
American journal of human genetics, 2012-07-13, Vol.91 (1), p.152-162
11.
Is venous thrombosis a risk factor for arterial thrombosis?
by Lowe, Gordon DO
The Lancet (British edition), 2007, Vol.370 (9601), p.1742-1744
12.
Blood Biomarkers for the Diagnosis of Acute Cerebrovascular Diseases: A Prospective Cohort Study
by Whiteley, William
Cerebrovascular diseases (Basel, Switzerland), 2011-08, Vol.32 (2), p.141-147
13.
Blood rheology and cognition in the Edinburgh Type 2 Diabetes Study
by Marioni, Riccardo E.
Age and ageing, 2010-05, Vol.39 (3), p.354-359
14.
Prevention of venous thromboembolism after major orthopaedic surgery: is fondaparinux an advance?
by Lowe, Gordon DO
The Lancet (British edition), 2003, Vol.362 (9383), p.504-505
15.
Total tooth loss and prevalent cardiovascular disease in men and women: Possible roles of citrus fruit consumption, vitamin C, and inflammatory and thrombotic variables
by Lowe, Gordon
Journal of clinical epidemiology, 2003, Vol.56 (7), p.694-700
16.
Inflammation, coagulation and risk of locomotor disability in elderly women: findings from the British Women's Heart and Health Study
by NÜESCH, Eveline
European journal of epidemiology, 2012-01-01, Vol.27 (8), p.633-645
17.
Statin therapy and the acute inflammatory response after coronary artery bypass grafting
by Brull, David J
The American journal of cardiology, 2001-08-15, Vol.88 (4), p.431-433
18.
Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment
by Lip, G. Y
British Heart Journal, 1995-06, Vol.73 (6), p.527-533
19.
A specific elevation in tissue plasminogen activator antigen in women with polycystic ovarian syndrome
by KELLY, Christopher J. G
The journal of clinical endocrinology and metabolism, 2002, Vol.87 (7), p.3287-3290
20.
Tissue plasminogen activator antigen predicts medium-term left ventricular end-systolic volume after acute myocardial infarction
by Weir, Robin A. P
Journal of thrombosis and thrombolysis, 2009-08-07, Vol.29 (4), p.421-428
